CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

SJG-136 2mg  | ≥98%

CSNpharm

SJG-136 is a rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.

More Information Supplier Page

SJG-136 10mg  | ≥98%

CSNpharm

SJG-136 is a rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.

More Information Supplier Page

SJG-136 25mg  | ≥98%

CSNpharm

SJG-136 is a rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.

More Information Supplier Page

SJG-136 5mg  | ≥98%

CSNpharm

SJG-136 is a rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity.

More Information Supplier Page

Skatole 100mg  | ≥99%

CSNpharm

Skatole (3-Methylindole) is a mildly toxic white crystalline organic compound that occurs naturally in feces. It has a fairly broad bacteriostatic effect.

More Information Supplier Page

SKF-34288 HCl 5mg  | ≥98%

CSNpharm

SKF-34288 HCl is a PEPCK inhibitor which could inhibit glucose synthesis through inhibition of PEPCK in the gluconeogenesis pathway.

More Information Supplier Page

SKF-34288 HCl 10mg  | ≥98%

CSNpharm

SKF-34288 HCl is a PEPCK inhibitor which could inhibit glucose synthesis through inhibition of PEPCK in the gluconeogenesis pathway.

More Information Supplier Page

SKF-34288 HCl 1mg  | ≥98%

CSNpharm

SKF-34288 HCl is a PEPCK inhibitor which could inhibit glucose synthesis through inhibition of PEPCK in the gluconeogenesis pathway.

More Information Supplier Page

SKF-38393 HCl 250mg  | ≥99%

CSNpharm

SKF-38393 HCl is an agonist of dopamine D1 receptor (the IC50 value is 110 nM). It has anorectic and stimulant effects.

More Information Supplier Page

SKF-38393 HCl 100mg  | ≥99%

CSNpharm

SKF-38393 HCl is an agonist of dopamine D1 receptor (the IC50 value is 110 nM). It has anorectic and stimulant effects.

More Information Supplier Page

SKF-86002 5mg  | ≥99%

CSNpharm

SKF-86002 is a potent inhibitor of p38 MAP kinase with IC50 of 0.5-1 μM and inhibits LPS-induced IL-1 and TNF-α production in human monocytes (IC50 = 1 μM).

More Information Supplier Page

SKF-86002 50mg  | ≥99%

CSNpharm

SKF-86002 is a potent inhibitor of p38 MAP kinase with IC50 of 0.5-1 μM and inhibits LPS-induced IL-1 and TNF-α production in human monocytes (IC50 = 1 μM).

More Information Supplier Page

SKF-86002 2mg  | ≥99%

CSNpharm

SKF-86002 is a potent inhibitor of p38 MAP kinase with IC50 of 0.5-1 μM and inhibits LPS-induced IL-1 and TNF-α production in human monocytes (IC50 = 1 μM).

More Information Supplier Page

SKF-86002 10mg  | ≥99%

CSNpharm

SKF-86002 is a potent inhibitor of p38 MAP kinase with IC50 of 0.5-1 μM and inhibits LPS-induced IL-1 and TNF-α production in human monocytes (IC50 = 1 μM).

More Information Supplier Page

SKF-89976A HCl 50mg  | ≥98%

CSNpharm

SKF-89976A HCl is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.

More Information Supplier Page

SKF-89976A HCl 10mg  | ≥98%

CSNpharm

SKF-89976A HCl is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.

More Information Supplier Page

SKF-89976A HCl 5mg  | ≥98%

CSNpharm

SKF-89976A HCl is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.

More Information Supplier Page

SKF-89976A HCl 25mg  | ≥98%

CSNpharm

SKF-89976A HCl is a selective GABA transporter (GAT-1) inhibitor with IC50s of 0.28 μM, 137.34 μM and 202.8 μM for GAT-1, GAT-2 and GAT-3 in CHO cells, respectively.

More Information Supplier Page

SKF-96365 HCl 5mg  | ≥98%

CSNpharm

SKF-96365 HCl is a transient receptor potential canonical type (TRPC) channel blocker, also bolcks voltage-gated Ca2+ channels and potassium channels.

More Information Supplier Page

SKF-96365 HCl 50mg  | ≥98%

CSNpharm

SKF-96365 HCl is a transient receptor potential canonical type (TRPC) channel blocker, also bolcks voltage-gated Ca2+ channels and potassium channels.

More Information Supplier Page

SKF-96365 HCl 10mg  | ≥98%

CSNpharm

SKF-96365 HCl is a transient receptor potential canonical type (TRPC) channel blocker, also bolcks voltage-gated Ca2+ channels and potassium channels.

More Information Supplier Page

SKF-96365 HCl 1mg  | ≥98%

CSNpharm

SKF-96365 HCl is a transient receptor potential canonical type (TRPC) channel blocker, also bolcks voltage-gated Ca2+ channels and potassium channels.

More Information Supplier Page

SKF-96365 HCl 100mg  | ≥98%

CSNpharm

SKF-96365 HCl is a transient receptor potential canonical type (TRPC) channel blocker, also bolcks voltage-gated Ca2+ channels and potassium channels.

More Information Supplier Page

SKF-96365 HCl 250mg  | ≥98%

CSNpharm

SKF-96365 HCl is a transient receptor potential canonical type (TRPC) channel blocker, also bolcks voltage-gated Ca2+ channels and potassium channels.

More Information Supplier Page

SKI V 1mg  | ≥98%

CSNpharm

for hPI3k. SKI V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P). SKI V induces apoptosis and has antitumor activity[1][2].

More Information Supplier Page

SKI V 10mg  | ≥98%

CSNpharm

for hPI3k. SKI V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P). SKI V induces apoptosis and has antitumor activity[1][2].

More Information Supplier Page

SKI V 5mg  | ≥98%

CSNpharm

for hPI3k. SKI V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P). SKI V induces apoptosis and has antitumor activity[1][2].

More Information Supplier Page

Skimmin 5mg  | ≥98%

CSNpharm

Skimmin, a natural product isolated and purified from the herbs of Hydrangea paniculata with anti-inflammatory activity, can significantly improve renal function and suppress the IgG deposition as well as the development of glomerular lesions in a rat model of membranous glomerulonephritis, suppress diabetic nephropathy in rats effectively, and may slow down the renal fibrosis by […]

More Information Supplier Page

Skullcapflavone I 1mg  | ≥98%

CSNpharm

Skullcapflavone I, a natural product isolated and purified from the roots of Scutellaria baicalensis Georgi, selectively induces apoptosis in T-HSC/Cl-6 cells via caspase-3 and caspase-9 activation.

More Information Supplier Page

Skullcapflavone I 5mg  | ≥98%

CSNpharm

Skullcapflavone I, a natural product isolated and purified from the roots of Scutellaria baicalensis Georgi, selectively induces apoptosis in T-HSC/Cl-6 cells via caspase-3 and caspase-9 activation.

More Information Supplier Page

Skyrin 1mg  | ≥98%

CSNpharm

Skyrin is a fungal bisanthroquinone. It exhibits functional glucagon antagonism by uncoupling the glucagon receptor from adenylate cyclase activation in rat liver membranes.

More Information Supplier Page

SL0101 1mg  | ≥98%

CSNpharm

SL0101 is a selective inhibitor of ribosomal S6 kinase (RSK) (IC50 = 89 nM for RSK2) which does not inhibit upstream kinases such as MEK, Raf and PKC. SL0101 Inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line.

More Information Supplier Page

SL0101 5mg  | ≥98%

CSNpharm

SL0101 is a selective inhibitor of ribosomal S6 kinase (RSK) (IC50 = 89 nM for RSK2) which does not inhibit upstream kinases such as MEK, Raf and PKC. SL0101 Inhibits the growth of MCF-7 human breast cancer cells with no effect on the normal breast cell line.

More Information Supplier Page